ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03) (NCT04829604)

🧪 Interventions in This Study

• ARX788 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (33 Sites)

Showing the first 25 of 33 sites.

• Research Site — Los Angeles, California
• Research Site — Newport Beach, California
• Research Site — San Francisco, California
• Research Site — Whittier, California
• Research Site — Atlanta, Georgia
• Research Site — Chicago, Illinois
• Research Site — Louisville, Kentucky
• Research Site — Silver Spring, Maryland
• Research Site — Boston, Massachusetts
• Research Site — St Louis, Missouri
• Research Site — Omaha, Nebraska
• Research Site — Las Vegas, Nevada
• Research Site — Camden, New Jersey
• Research Site — New Hyde Park, New York
• Research Site — New York, New York
• Research Site — Shirley, New York
• Research Site — The Bronx, New York
• Research Site — Portland, Oregon
• Research Site — Tigard, Oregon
• Research Site — Philadelphia, Pennsylvania
• Research Site — Dallas, Texas
• Research Site — Houston, Texas
• Research Site — San Antonio, Texas
• Research Site — Norfolk, Virginia
• Research Site — Tacoma, Washington

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All HER2 Positive Metastatic Breast Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.